Inspire Medical Systems ROE 2017-2025 | INSP
Current and historical return on equity (ROE) values for Inspire Medical Systems (INSP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Inspire Medical Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.07B | $0.64B | 9.92% |
| 2024-12-31 | $0.05B | $0.69B | 8.11% |
| 2024-09-30 | $0.03B | $0.70B | 5.29% |
| 2024-06-30 | $0.01B | $0.64B | 1.02% |
| 2024-03-31 | $-0.02B | $0.59B | -2.86% |
| 2023-12-31 | $-0.02B | $0.57B | -3.91% |
| 2023-09-30 | $-0.03B | $0.54B | -6.36% |
| 2023-06-30 | $-0.04B | $0.53B | -8.20% |
| 2023-03-31 | $-0.04B | $0.51B | -10.13% |
| 2022-12-31 | $-0.05B | $0.50B | -12.69% |
| 2022-09-30 | $-0.05B | $0.47B | -17.38% |
| 2022-06-30 | $-0.04B | $0.23B | -19.09% |
| 2022-03-31 | $-0.04B | $0.23B | -18.79% |
| 2021-12-31 | $-0.04B | $0.23B | -18.39% |
| 2021-09-30 | $-0.05B | $0.22B | -20.60% |
| 2021-06-30 | $-0.05B | $0.22B | -20.40% |
| 2021-03-31 | $-0.06B | $0.22B | -24.45% |
| 2020-12-31 | $-0.06B | $0.23B | -27.32% |
| 2020-09-30 | $-0.06B | $0.23B | -31.78% |
| 2020-06-30 | $-0.06B | $0.23B | -34.62% |
| 2020-03-31 | $-0.04B | $0.13B | -29.03% |
| 2019-12-31 | $-0.03B | $0.14B | -22.18% |
| 2019-09-30 | $-0.03B | $0.15B | -18.74% |
| 2019-06-30 | $-0.03B | $0.15B | -18.21% |
| 2019-03-31 | $-0.02B | $0.16B | -18.39% |
| 2018-12-31 | $-0.02B | $0.16B | -25.56% |
| 2018-09-30 | $-0.02B | $0.10B | -44.67% |
| 2018-06-30 | $-0.02B | $0.10B | -84.85% |
| 2018-03-31 | $-0.02B | $-0.01B | 2000.00% |
| 2017-12-31 | $-0.02B | $0.00B | -6800.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.033B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.227B | 59.07 |
| Hims & Hers Health (HIMS) | United States | $12.367B | 128.49 |
| Tempus AI (TEM) | United States | $12.011B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.742B | 0.00 |
| Hinge Health (HNGE) | United States | $2.855B | 0.00 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Schrodinger (SDGR) | United States | $1.917B | 0.00 |
| Enovis (ENOV) | United States | $1.916B | 10.69 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.522B | 0.00 |
| Omnicell (OMCL) | United States | $1.463B | 25.82 |
| Azenta (AZTA) | United States | $1.393B | 64.72 |
| 10x Genomics (TXG) | United States | $1.311B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.663B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.645B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.33 |
| Outset Medical (OM) | United States | $0.366B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.288B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 3.60 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |